HomeCompareEMPO vs ARCC

EMPO vs ARCC: Dividend Comparison 2026

EMPO yields 500000.00% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMPO wins by $4.663521010693878e+33M in total portfolio value
10 years
EMPO
EMPO
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full EMPO calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — EMPO vs ARCC

📍 EMPO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMPOARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMPO + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMPO pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMPO
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, EMPO beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMPO + ARCC for your $10,000?

EMPO: 50%ARCC: 50%
100% ARCC50/50100% EMPO
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

EMPO
No analyst data
Altman Z
-1.0
Piotroski
2/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMPO buys
0
ARCC buys
0
No recent congressional trades found for EMPO or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMPOARCC
Forward yield500000.00%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$4.663521010693878e+33M$24.5K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$1.16
Total dividends collected$4.6634009849658873e+33M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: EMPO vs ARCC ($10,000, DRIP)

YearEMPO PortfolioEMPO Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,381$541.15+$50.00MEMPO
2$233,748,371,262$233,694,859,813.08$12,621$284.08+$233748.36MEMPO
3$1,021,074,511,412,696$1,020,824,400,655,446.10$13,827$145.31+$1021074511.40MEMPO
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$15,062$73.43+$4168597328794.94MEMPO
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$16,364$36.89+$15905475114600664.00MEMPO
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$17,757$18.49+$56718938532531060736.00MEMPO
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$19,258$9.25+$1.8903180743562385e+23MEMPO
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$20,880$4.63+$5.8879981047651824e+26MEMPO
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$22,636$2.32+$1.7140642681147225e+30MEMPO
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$24,539$1.16+$4.663521010693878e+33MEMPO

EMPO vs ARCC: Complete Analysis 2026

EMPOStock

Empowered Products, Inc., together with its subsidiaries, manufactures, sells, and distributes personal care products principally in the United States, Europe, and Asia. It provides various products, including topical gels, lotions, and oils, which are designed to enhance a person's mental focus and to improve the bond of interpersonal relationships. The company sells 12 formulated skin lubricants under PINK for women and GUN OIL for men trademarks. It offers various products for men, such as GUN OIL Silicone, a silicone-based interactive lubricant; GUN OIL H2O, a water-based interactive lubricant; GUN OIL Force Recon, a combination water and silicone interactive lubricant; GUN OIL Gel, a gelatinous lubricant for men's personal toys; GUN OIL Stroke 29, a self-applied men's personal lubricant; GUN OIL Loaded, a silicone infused cream hybrid interactive lubricant; GUN OIL Jack Jelly, a self-applied men's personal lubricant in gelatinous form; and GUN OIL Shine, a personal toy cleaner. The company also provides products for women comprising PINK Silicone, an interactive lubricant with silicone vitamin E and aloe vera; PINK Water, a water-based interactive lubricant with vitamin E and aloe vera; Hot PINK, an exothermic massage lubricant; PINK Frolic, a women's personal toy lubricant; PINK Unity, a gelatinous hybrid lubricant with silicone and water; PINK Indulgence Crème, a hybrid cream interactive lubricant; and PINK Sparkle, a personal toy cleaner. Empowered Products, Inc. sells its products directly to retailers, as well as to consumers through its online Wellness Stores. The company is headquartered in Las Vegas, Nevada.

Full EMPO Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this EMPO vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMPO vs SCHDEMPO vs JEPIEMPO vs OEMPO vs KOEMPO vs MAINEMPO vs HTGCEMPO vs GBDCEMPO vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.